Harold Schwartz, MD
Gastroenterology · Hamden, CTNPI 1760432256
Payments from drug & device makers
Across 68 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$267
- AbbVie$203
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$141
- Johnson & Johnson$108
- Pfizer$106
- QOL Medical, LLC$57
- plus $295 from 11 others
What the payments were for
- Food & beverage$1,15398%
- Education$252%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $267 |
| AbbVie(2 entities) | 10 | $203 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $141 |
| Johnson & Johnson | 6 | $108 |
| Pfizer | 7 | $106 |
| QOL Medical, LLC | 7 | $57 |
| Gilead | 4 | $53 |
| Phathom Pharmaceuticals, Inc. | 3 | $44 |
| Ironwood Pharmaceuticals, Inc | 2 | $33 |
| Exact Sciences | 1 | $32 |
| Boston Scientific | 1 | $24 |
| UCB, Inc. | 2 | $24 |
| Evoke Pharma, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Redhill Biopharma Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Merck | 1 | $14 |
How this compares
$1,177 in reported general payments places this provider in the 30th percentile of 326 gastroenterology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 24 | $311 |
| Omeprazole | 16 | $61 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Hamden
- Paul FeuerstadtHamden$1.4M
- Renuka UmashankerHamden$197K
- David HassHamden$190K
- Pramod MistryNew Haven$6M
- Salam ZakkoBristol$2.7M
- Angelo ParedesMiddletown$1.3M
- James FrestonFarmington$778K
- Jill GaidosNew Haven$750K
- Houman RezaizadehFarmington$720K
- James BoyerNew Haven$648K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.